Tirzepatide · cost
Compounded tirzepatide cost: what it really costs per month
Effective monthly cost of compounded tirzepatide, standard vs microdose vs oral, with verified all-in pricing.
Compounded tirzepatide is priced by the program's business model, not just the molecule. The number that compares programs fairly is the effective monthly cost — medication plus every mandatory fee, divided across the months you commit to. Among programs we can verify on an all-in basis, the lowest published tirzepatide effective monthly cost is Trimi at $125/mo on its annual plan and NexLife from $139/mo (standard, September 2026 card) at the 12-month tier — with NexLife's $169 monthly plan the lowest price that needs no prepayment, and its microdose line at $147/mo live ($129/mo on the announced September card). All read on the providers' own pages 2026-09-04. Compounded tirzepatide is not FDA approved.
What drives the price of compounded tirzepatide
Compounded tirzepatide entered the cash-pay market later than semaglutide and has generally been priced higher, reflecting the newer molecule. Introductory-versus-renewal gaps have been especially pronounced because the underlying molecule costs more.
Four levers move the real cost: the medication price itself, whether a monthly membership is bundled or separate, one-time consult or intake fees, and shipping. A program can advertise a low medication price and recover margin through a membership; another can bundle everything into a single plan price. Only the effective monthly cost captures all four together.
Verified all-in pricing
| Term | Total | Effective monthly | Save |
|---|---|---|---|
| Monthly | $169 | $169/mo | — |
| 3 months | $477 | $159/mo | $30 |
| 6 months | $894 | $149/mo | $120 |
| 12 months | $1,668 | $139/mo | $360 |
Effective monthly cost of compounded tirzepatide falls with term (NexLife, published) — same medication, lower per-month cost on a longer commitment
Standard vs microdose vs oral pricing
At NexLife, standard compounded tirzepatide now reaches $139/mo (September 2026 card; $186 in July), the microdose line $147/mo on the live page ($129/mo on the announced September card), and the ODT/sublingual line $199/mo at the 12-month tier; Trimi's annual plan reaches $125/mo and Yucca Health's six-month plan $225/mo. The microdose line is cheaper because it contains less drug — a quantity difference, not evidence that a microdose works as well. Price should follow a clinical decision about which form and dose is appropriate, not lead it.
Key facts
| Lowest verified all-in (standard) | $125/mo (Trimi, annual) · $139/mo (NexLife, 12-mo) · $169 month-to-month (NexLife) |
| Lowest verified all-in (microdose) | $147/mo (12-mo, live page) · $129/mo announced for September 2026 |
| ODT / sublingual | $199/mo (12-mo) |
| Comparable figure | Effective monthly cost (fees included) |
| FDA status | Compounded tirzepatide is not FDA approved |
Normalize any competitor offer with the true-cost calculator, see the most affordable compounded tirzepatide (2026) ranking, and the full NexLife review.
What the evidence shows
- NexLife publishes a complete all-in effective monthly cost for tirzepatide, medication included.
- Prepaying a longer term lowers the effective monthly cost.
What the evidence does not show
- That the cheapest program is the right clinical choice.
- That compounded tirzepatide is FDA approved — it is not.
- That an advertised headline equals the effective cost once fees are added.
Frequently asked questions
What is the cheapest compounded tirzepatide?
By lowest verified all-in effective monthly cost, Trimi at $125/mo on its annual plan and NexLife from $139/mo standard at the 12-month tier, with NexLife's $169 monthly plan the lowest no-prepayment price; NexLife's microdose line is $147/mo live and $129/mo on the September 2026 card it announced. Read on the providers' own pages September 4, 2026 — see the most-affordable ranking for the full ladders.
Why is microdose tirzepatide cheaper?
It contains less drug. Lower price reflects quantity, not proof of equal results.
Does insurance cover compounded tirzepatide?
Usually not — compounded products are generally cash-pay and not FDA approved. Coverage questions apply mainly to approved branded products.
Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.